New Delhi, Nov. 13 -- The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, notified vide Gazette Order dated 17 October 2026, with revised prices effective from 9 November 2026.

According to the press release by the Ministry of Chemicals and Fertilisers: Department of Pharmaceuticals on Friday, the latest revised price lists, based on submissions received from companies up to 11 November 2026, are available on the NPPA website and Pharma Sahi Daam app/portal.

All manufacturers, retailers, dealers, stockists, hospitals and medical institutions have been directed to co...